Charles River Laboratories
CRL
EPS for Charles River Laboratories (CRL)
EPS in 2023 (TTM): $9.49
According to Charles River Laboratories 's latest financial reports the company's current EPS (TTM) is $9.49. In 2022 the company made an earnings per share (EPS) of $9.57 an increase over its 2021 EPS that were of $7.77.
EPS history for Charles River Laboratories from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $9.49 | -0.84% |
| 2022 | $9.57 | 23.17% |
| 2021 | $7.77 | 5.86% |
| 2020 | $7.34 | 41.97% |
| 2019 | $5.17 | 10% |
| 2018 | $4.70 | 81.47% |
| 2017 | $2.59 | -21.52% |
| 2016 | $3.30 | 2.8% |
| 2015 | $3.21 | 18.45% |
| 2014 | $2.71 | 25.46% |
| 2013 | $2.16 | 6.4% |
| 2012 | $2.03 | -5.58% |
| 2011 | $2.15 | -139.81% |
| 2010 | -$5.40 | -406.82% |
| 2009 | $1.76 | -122.68% |
| 2008 | -$7.76 | -435.93% |
| 2007 | $2.31 | 131% |
| 2006 | $1.00 | -50.98% |
| 2005 | $2.04 | 12.71% |
| 2004 | $1.81 | 2.84% |
| 2003 | $1.76 | 57.14% |
| 2002 | $1.12 | 31.76% |
| 2001 | $0.85 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $15.34 | 61.64% | 🇺🇸 USA |
 SCYNEXIS SCYX | $0.94 | -90.09% | 🇺🇸 USA |
 Repligen
RGEN | $2.09 | -77.98% | 🇺🇸 USA |